01/04/2015 |
Initial presentation with lower abdominal pain and
vaginal bleeding |
02/04/2015 |
Abdominal CT and MRI revealed bilateral annexal
masses and pelvic effusion |
03/04/2015 |
Laboratory tests showed AFP 3630ng/ml, CA125 337.9
U/ml, HE4 142.7pmol/L |
20/04/2015 |
Maximal debulking surgery |
29/04/2015 |
Discharge from hospital |
11/05/2015 |
Administration of the first course of chemotherapy
(paclitaxel and carboplatin) |
11/05/2016 |
Administration of the ninth course of chemotherapy
(paclitaxel and carboplatin) |
19/08/2016 |
MRI showed no sign of recurrence, with serum AFP and
CA125 in normal range |
01/12/2016 |
MRI showed no sign of recurrence, with serum AFP and
CA125 in normal range |
31/03/2017 |
PET/CT showed no abnormal increase in FDG metabolism
through systemic imaging |
April to May/2017 |
Laboratory tests showed rapidly elevated
serum CA125 and AFP |
07/05/2017 |
Complaint of abdominal pain, distension and stop
defecating |
08/05/2017 |
MRI revealed pelvic effusion and metastasis in
omentum, peritoneum and mesenteric nodules |
19/05/2017 |
Start chemotherapy (paclitaxel and
carboplatin) |
12/10/2017 |
Stop chemotherapy due to severe adverse
events |
20/11/2017 |
CT revealed pleural effusion and a large amount of
peritoneal effusion with multiple small nodules in the peritoneum and
swollen retroperitoneal lymph nodes |
In Early 2018 |
Our patient passed away due to cachexia and
multiple organ failure |